Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study.

Takagi, T; Akasaka, T; Yamamuro, A; Honda, Y; Hozumi, T; Morioka, S; Yoshida, K

Takagi, T; Akasaka, T; Yamamuro, A; Honda, Y; Hozumi, T; Morioka, S; Yoshida, K.

Affiliation

Takagi T; Division of Cardiology, Kobe General Hospital, Japan. tx-tkg@ka2.so-net.ne.jp

J Am Coll Cardiol ; 36(5): 1529-35, 2000 Nov 01.

Article in En | MEDLINE | ID: mdl-11079654

Subject(s)

Chromans/pharmacology; Coronary Disease/diagnostic imaging; Coronary Disease/drug therapy; Diabetes Mellitus, Type 2/complications; Diabetic Angiopathies/diagnostic imaging; Diabetic Angiopathies/drug therapy; Hypoglycemic Agents/pharmacology; Stents; Thiazoles/pharmacology; Thiazolidinediones; Tunica Intima/drug effects; Tunica Intima/pathology; Ultrasonography, Interventional; Cell Division; Coronary Disease/complications; Coronary Disease/pathology; Diabetic Angiopathies/pathology; Female; Humans; Male; Middle Aged; Troglitazone

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Stents / Chromans / Tunica Intima / Ultrasonography, Interventional / Coronary Disease / Thiazolidinediones / Diabetes Mellitus, Type 2 / Diabetic Angiopathies / Hypoglycemic Agents Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: J Am Coll Cardiol Year: 2000 Type: Article Affiliation country: Japan

Search on Google

XML

PubMed Links